2 ] are at increased risk of all-cause mortality as a result of metabolic sequelae including hyperlipidemia, hypertension, and diabetes. Bariatric surgery has been shown to reduce the severity of the metabolic complications of obesity. Method: A case-controlled analysis was carried out of patients with a BMI of 35 kg/m 2 or more from the Clinical Practice Research Datalink, a UK database of primary care clinics. Clinicopathological characteristics at baseline diagnosis were extracted. Cases of all-cause mortality were identified as a clinical endpoint. A Cox proportional hazard model was used to calculate hazard ratios (HRs) for different patient factors. A P value less than 0.050 was defined as significant. Results: A total of 187,061 records were identified for analysis. Median follow-up time was 98.0 months (range: 3.0-1095.0). A total of 8655(4.6%) were identified as having died during the study period. The median time from baseline obesity diagnosis until death was 137.0 months (range: 3.0-628.7). Multivariate analysis found bariatric surgery to be associated with reduced risk of all-cause mortality (HR: 0.487; P < 0.001). The following were associated with increased risk of death: male sex (HR: 1.805; P < 0.001), BMI of 60 or greater (HR: 2.541; P < 0.001), hypertension (HR: 2.108; P < 0.001), diabetes (HR: 2.766; P < 0.001), and hyperlipidemia (HR: 1.641; P < 0.001).
, is associated with a significant health burden for both the individual and health care systems. 1, 2 Obesity is associated with an increased risk of a number of diseases, including type II diabetes, hypertension, ischemic heart disease, and cancer. [2] [3] [4] [5] [6] The continued rise in prevalence of obesity during the past 50 years subsequently presents a challenge to health systems globally. 7 In the United States, the number of adults who are now obese stands at around 35%, having grown by more than 2% during a decade. 8 In the United Kingdom, 7 out of 10 people are projected to be either overweight or obese by 2020. 2 Previous high-impact meta-analyses have been conducted to elucidate the effect of BMI on all-cause mortality. [9] [10] [11] From these, a J-shaped curve has been identified. Patients with a BMI between 20 and 25 kg/m 2 have the lowest relative risk of all-cause mortality, whereas underweight and overweight patients are at increased risk, and patients at the highest extremes of BMI are at the most risk. The impact of obesity on health is not just a result of weight alone but also the metabolic sequelae that are propagated by increased adiposity. A previous analysis of the Clinical Practice Research Datalink (CPRD) from the United Kingdom between 1988 and 1998 identified factors which are associated with increased risk of death in a severely obese population; including age, type 2 diabetes mellitus, male sex, and smoking. 12 The CPRD collects data from primary care physicians, and accounts for 8.9% of the UK population, leading to robust retrospective analysis, as previously described. 13 Since the previous analysis, a number of new patients with severe obesity have been entered into the CPRD, allowing for an analysis of a modern cohort of patients, who are subject to a heavily ''obesogenic'' environment. 14 The aim of this study was to therefore evaluate the risk factors for all-cause mortality within the severely obese population of the United Kingdom, including those risk factors ignored in previous analyses of the CPRD.
METHODS

Study Design and Database
A case-controlled analysis was conducted in a population of patients with severe obesity (BMI !35 kg/m 2 ) from the CPRD. The CPRD is a record of coded data from more than 625 primary care practices in the United Kingdom, representing more than 12 million patients. The CPRD has previously been verified as a representative sample of the UK population. 13, 15 Cases of all-cause mortality were identified from mortality data registered in the CPRD. These were analyzed against controls that were still alive at data extraction.
Ethics
Scientific approval was obtained from the Regulatory Agency's Independent Scientific Advisory Committee, and ethical approval was sought through the Health Research Authority (IRAS Project ID: 203143, ISAC approval registration number 16_140R2).
Patient and Data Selection
Patients with a BMI of 35 kg/m 2 or greater were identified from the CPRD via clinical coding provided by general practitioners. The date at which the patients were first identified as severely obese was found by interrogation of the datalink. In addition to this, the clinicopathological characteristics of each patient at baseline were extracted from the CPRD. These included age, sex, BMI, hypertension, type II diabetes mellitus, hyperlipidemia, ischemic heart disease, obstructive sleep apnea, cerebrovascular disease, and chronic respiratory disease. BMI was calculated from height and weight and compared against BMI values inputted by primary care physicians into the CPRD. Where these did not agree, calculated values were used in preference to coded BMI. These factors were identified as being present at baseline if patients had a positive diagnosis before being identified as having a BMI of 35 kg/m 2 or greater, or were diagnosed in the following 6 months. This was to control for underlying disease that may have gone undiagnosed clinically when BMI was assessed. It was also identified whether patients had ever been a smoker of tobacco products. Patients who underwent bariatric surgery in the following years were also identified from the CPRD. Those who were eligible for bariatric surgery according to the National Institute of Care and Excellence guidelines were identified. 16 Finally, patients were linked to index of multiple deprivation (IMD) scores. The IMD is a surrogate score of the socioeconomic background of a neighborhood, considering the following factors: income, employment, health deprivation and disability, educational attainment, barriers to housing and services, crime, and living environment. 17 
Statistical Analysis
Demographic factors were analyzed by either Students t test, Mann-Whitney test, or chi-square test depending on whether they were continuous or categorical variables. Means are displayed alongside the standard deviation, whereas median values are provided with the range. Statistical significance was set at P value less than 0.050. A Cox proportional hazard model was conducted to identify the hazard ratios (HRs) for risk of death associated with several categorical variables, via a univariate analysis. Variables with HRs that were calculated to have a P value less than 0.050 were included in a multivariate analysis. Significance of the multivariate analysis was again set at P value less than 0.050. Missing data values were removed from univariate and multivariate analysis. Data were read and analyzed using Statistical Package for the Social Sciences (IBM Statistics version 24 SPSS Inc., Chicago, IL).
RESULTS
On primary CPRD interrogation, up until July 2017, 231,399 patients were identified as obese. After restricting for patients with a BMI of 35 or more and BMI less than 80, there were 231,316 patients remaining. After controlling for extremes of age, 187,061 remained for final quantitative analysis. The median follow-up time from first diagnosis of BMI of 35 kg/m 2 or more until final patient visit or patient death was 98.0 months (range: 3.0-1095.0 months). Of those included, 8655 (4.6%) were identified as having died over the study period. The median time from baseline obesity diagnosis until death was 137.0 (range: 3.0-628.7 months). Table 1 outlines the primary demographic details in full for those patients who were both deceased and non-deceased at last follow-up. The deceased patients were older at baseline diagnosis (mean: 49.40 AE 8.79 vs 39.70 AE 11.48; P < 0.001). Deceased patients were also more likely to be men (43.3% vs 31.6%; P < 0.001). The BMI at baseline was higher in patients who died (39.86 AE 5.46 vs 38.80 AE 4.43; P < 0.001). A total of 93,313 patients (49.9%) in both groups were eligible for bariatric surgery according to National Institute of Care and Excellence guidelines at baseline. 16 Only 3,869 (2.1%), however, received surgical intervention for their obesity. Of those who died during follow-up, 5881 (67.9%) patients were eligible for surgery; however, only 47 (0.5%) received bariatric intervention.
Overall Survival
At 5 years from initial coding of severe obesity, overall survival was 99.1% (n ¼ 185,300). At 10 years, overall survival was 97.9% (n ¼ 183,172). Overall survival was 96.8% (n ¼ 181,119) at 15 years, and 95.9% (n ¼ 179,375) at 20 years. Table 2 details the factors included in a Cox proportional hazard model to determine their association with all-cause mortality. The following factors were all found to be associated with an increased likelihood of death on univariate analysis: increased age at first diagnosis, male sex, higher BMI categories, hypertension, type II diabetes mellitus, hyperlipidemia, ischemic heart disease, cerebrovascular disease, chronic respiratory disease, obstructive sleep apnea (all P < 0.001), and smoking (P ¼ 0.014). Patients who underwent bariatric surgery had a reduced association with mortality (P < 0.001).
Univariate Analysis
Multivariate Analysis
The results of the subsequent multivariate analysis are included in Table 3 . Again, the following were associated with increased mortality: increased age at first diagnosis, male sex, higher BMI categories, hypertension, type II diabetes mellitus, hyperlipidemia, ischemic heart disease, cerebrovascular disease, chronic respiratory disease, obstructive sleep apnea, and smoking (all P < 0.001). Bariatric surgery was found to be associated with protection from allcause mortality (P < 0.001).
DISCUSSION
Severe obesity is well known to increase the likelihood of allcause mortality at an earlier age compared to people with a normal BMI. [9] [10] [11] When patients are first identified as severely obese, it is common for them to concurrently experience the metabolic sequelae of obesity at the same time. In the group of patients from this analysis; 12.7%, 5.4%, and 1.9% of patients had hypertension, type II diabetes, and hyperlipidemia, respectively at baseline. It is, however, not clear which factors at baseline place the patients at greatest risk of all-cause mortality. The results from this analysis indicate that a number of individual risk factors that are prevalent amongst the severely obese population are prognostic of overall survival. Those most heavily associated with an increased risk of death appear to be a high BMI, late age at diagnosis, hypertension, type II diabetes, and obstructive sleep apnea. Those patients who, however, had bariatric surgery were also at reduced risk of all-cause mortality. These results suggest that increasing obesity beyond BMI of 35 kg/m 2 or more is independently associated with increased risk of death. Multivariate analysis identified that the highest BMI categories are at greatest risk of all-cause mortality, despite controlling for a number of other disease parameters that were also independently associated with a heightened risk of mortality. The risks of obesity were traditionally believed to be due to developing metabolic sequelae that increase cardiovascular disease risk, as well as increasing risk of cancer and other chronic health conditions. 18, 19 These findings run contrary to that hypothesis. The most likely reason behind this finding is that a greater BMI places an increasing disease burden upon patients which cannot be accounted for in the present analysis. However, recent findings have demonstrated a trend between obesity and risk of mortality independent of those sequelae. These patients are otherwise referred to as the ''metabolically healthy obese.'' These patients have a risk between that of metabolically healthy normal weight persons and metabolically unhealthy obese individuals. 20 In addition to initial baseline risk, approximately 30% of these patients become metabolically at risk after being previously healthy. 21 The reason behind why some patients remain metabolically healthy is unclear and is thought to be due to interplay between genetic and environmental factors. 20 Regardless, it is important to encourage weight loss in all severely obese patients regardless of their metabolic status due to the increased risk it places on them.
This study also indicates that the socioeconomic environment in which a person lives is important for determining future risk of mortality. There is an ''obesity paradox'' which exists within developed countries in which those who live closer to the poverty line are at increased risk of obesity. 22 The largest proportion of this severely obese population is similarly derived from areas of the UK with the highest levels of depravation (IMD ¼ 5). The patients from these areas were similarly found to be at increased risk of all-cause mortality. This is corroborated by research that has identified health inequalities between different communities depending on socioeconomic factors. 23 Altogether, these results highlight the importance of public health initiatives to improve access to healthcare and health education to reduce inequality in health outcomes.
In addition to these a number of metabolic comorbidities were associated with all-cause mortality when present at baseline diagnosis. All those factors that have been previously demonstrated to lead to worse outcomes (hypertension, type II diabetes, hyperlipidemia) in patients with obesity showed a significant correlation with allcause mortality. [24] [25] [26] [27] This is not only due to poorer cardiovascular outcomes. Demissie et al 25 have previously described that hypertension and insulin resistance in particular play a role in premature ageing. This highlights that severely obese patients with comorbidities are at increased risk. Importantly, effective treatments are available for these conditions and when they are well controlled can lead to improved outcomes. [28] [29] [30] Subsequently, it is important these are identified early in the severely obese to initiate appropriate therapy.
An interesting finding of this study is that those patients who underwent bariatric surgery were at reduced risk of all-cause mortality (HR ¼ 0.487). The most recent meta-analysis on the topic demonstrated similar findings. 31 The evidence in support of bariatric surgery in regards to primary endpoints of reduced mortality is becoming increasingly convincing. This is in addition to longstanding evidence supporting its effects on type II diabetes and hypertension, in addition to its cost-effectiveness. [32] [33] [34] It is clear from this analysis however that bariatric surgery is not widely used within the severely obese population in the United Kingdom. Out of those patients for who were eligible for bariatric surgery, only 4.1% of patients went on to have an intervention. Welbourn et al 35, 36 have previously highlighted both national and global discrepancy in access to bariatric surgery due to a number of barriers along the referral pathway. A survey questionnaire of primary care staff in the United Kingdom identified that while 86% would use the bariatric service they encountered barriers such as ''remote location,'' ''insufficient awareness,'' ''fear of complications,'' and ''lack of information.'' 37 A recent report from the Royal College of Surgeons also identified that 3% of Clinical Commissioning Groups have policies that do not follow national guidelines and subsequently restrict access to bariatric surgery. 38 Meanwhile, a recent analysis by Bhanderi et al 39 identified factors that may reduce access to bariatric procedures, including geographic variability and local deprivation. Reduction of such barriers to bariatric surgery would most likely therefore help improve all-cause mortality in the severely obese population in the United Kingdom.
The present study reports on a large population of severely obese patients from the CPRD, a database that has been previously demonstrated to be representative of the UK population. 13, 15 The number of patients involved significantly adds to the strength of the study and allows the results to be generalizable across the population as a whole as it is carried out in a real-life setting. A limitation of database research is that the quality of information is reliant on the accuracy of recording. To minimize the risk of misclassification, extremes of BMI beyond 80 kg/m 2 were removed. This only removed 83 patients from the analysis, but helped improve accuracy of the patient coding by eliminating outliers. To further eliminate misclassification of BMI we used values calculated from height and weight in preference to clinical coded values, as previous reports have identified the coded BMI values are recorded less frequently. 40 The reported prevalence of comorbidities in the present study is lower than reported in series that are not reliant on coded data. 19 As such this may bias the overall results; however, any misclassification that is present would likely bias the results toward the null. As a result, this would under-represent the strength of each factor on multivariate analysis rather than overstating the findings. In addition, in comparison to Office of National Statistics data the CPRD has been shown to record deaths later than their actual date (median 5 days). 41 This, however, has limited impact on the present analysis which is conducted across the timescale of months to years. Another factor that limits the results is inconsistencies in follow-up. Without a structured follow-up protocol, the protocol is reliant upon patients presenting to their primary care practitioner to enable diagnoses to be made. To reduce the effect of this bias, all comorbidities were taken at baseline diagnosis. This would subsequently again cause the results to tend toward the null, rather than overstate the findings. Finally, it is important to recognize that whilst multivariate analysis aims to identify the individual effect size of different risk factors, it is not able to control for all possible confounders.
CONCLUSIONS
The results from this study suggest a number of factors are associated with a poorer prognosis in the severely obese, most notably: high BMI, late age at diagnosis, hypertension, type II diabetes mellitus, and obstructive sleep apnea. In addition to this bariatric surgery is associated with improved survival; however, it is underutilized in the severely obese population of the United Kingdom. Effective public health campaigns, and improved access to bariatric surgery could improve outcomes in the severely obese.
